Skip to main content

Table 3 Costs of EGFR testing, erlotinib and afatinib prescriptions

From: Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma

 

Costs to Medicare

Patient out-of-pocket costs

Cost of EGFR testing (N = 1086)

 Mean (SD)

$1767 ($1511)

$350 ($339)

 Median

$1,483

$293

 Interquartile range

$798, $2234

$96, $477

 Range

($0-$14,661)

($0-$3028)

Average cost of a 30-day prescription of erlotinib (N = 394)

 Mean (SD)

$5938 ($882)

$594 ($725)

 Median

$6,114

$240

 Interquartile range

$5460, $6615

$1, $973

 Range

($2180-$7390)

($0-$2838)

Average cost of a 30-day prescription of afatinib (N = 42)

 Mean (SD)

$6267 ($735)

$605 ($722)

 Median

$6,239

$471

 Interquartile range

$5898, $6841

$1, $902

 Range

($4203-$7256)

($0-$2771)